A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users

Health Psychology

Volumn 22, Issue 2, 2003, Pages 223-228

  Margolin, Arthur ^a   Avants, S Kelly ^a   Warburton, Lara A ^a   Hawkins, Keith A ^a   Shi, Julia ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Adherence; HIV; Methadone; Risk behavior

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; DIAMORPHINE; ILLICIT DRUG; NARCOTIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; NEEDLE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; SEXUAL BEHAVIOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HIV SEROPOSITIVITY; HUMANS; MALE; MANUALS; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0037336043     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/0278-6133.22.2.223     Document Type: Article

References (33)

1. Avants, S. K. (2001). The HIV+ Harm Reduction Program for HIV-positive injection drug users (HHRP+). New Haven, CT: Yale University School of Medicine.
2. Avants, S. K., Margolin, A., Warburton, L. A., Hawkins, K. A., & Shi, J. (2001). Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. American Journal on Addictions, 10, 1-10.
3. Avants, S. K., Warburton, L. A., Hawkins, K. A., & Margolin, A. (2000). Continuation of high risk behaviors by HIV-positive drug users: Treatment implications. Journal of Substance Abuse Treatment, 19, 15-22.
4. Blackard, J. T., Cohen, D. E., & Mayer, K. H. (2002). Human immunodeficiency virus superinfection and recombination: Current state of knowledge and potential clinical consequences. Clinical Infectious Diseases, 34, 1108-1114.
5. Bryan, A. D., Fisher, J. D., Fisher, W. A., & Murray, D. M. (2000). Understanding condom use among heroin addicts in methadone maintenance using the information-motivation-behavioral skills model. Substance Use & Misuse, 35, 451-471.
6. Campsmith, M. L., Nakashima, A. K., & Jones, J. L. (2000). Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. Journal of Acquired Immune Deficiency Syndrome, 25, 192-198.
7. Carey, M. P., Braaten, L. S., Maisto, S. A., Gleason, J. R., Forsyth, A. D., Durant, L. E., & Jaworski, B. C. (2000). Using information, motivational enhancement, and skills training to reduce the risk of HIV infection for low-income urban women: A second randomized clinical trial. Health Psychology, 19, 3-11.
8. Carroll, K. M., Kadden, R. M., Donovan, D. M., Zweben, A., & Rounsaville, B. J. (1994). Implementing treatment and protecting the validity of the independent variable in treatment matching studies. Journal of Studies on Alcohol, 12(Suppl.), 149-155.
9. Carroll, K. M., Nich, C., Sifry, R. L., Nuro, K. F., Frankforter, T. L., Ball, S. A., et al. (2000). A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug & Alcohol Dependence, 57, 225-238.
10. Duran, S., Solas, C., Spire, B., Carrieri, M. P., Fuzibet, J. G., Costagliola, D., et al. (2001). Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy? A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study. AIDS, 15, 1075-1077.
11. Farinpour, R., Martin, E. M., Seidenberg, M., Pitrak, D. L., Pursell, K. J., Mullane, K. M., et al. (2000). Verbal working memory in HIV-seropositive drug users. Journal of the International Neuropsychological Society, 6, 548-555.
12. Fisher, J. D., & Fisher, W. A. (1992). Changing AIDS-risk behavior. Psychological Bulletin, 111, 455-474.
13. Fisher, J. D., Fisher, W. A., Bryan, A. D., & Misovich, S. (2002). Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychology, 21, 177-186.
14. Fisher, J. D., Kimble, D., Misovich, S. J., & Weinstein, E. (1998). Dynamics of HIV risk behavior in HIV-infected men who have sex with men. AIDS and Behavior, 2, 101-113.
15. Fisher, J. D., Misovich, S. J., Kimble, D., & Weinstein, E. (1999). Dynamics of HIV risk behavior in HIV-infected injecting drug users. AIDS and Behavior, 3, 41-57.
16. Hoffman, J. (1996). HIV and drug abuse: Brothers and sisters [Motion picture]. (Available from Danya International, Inc., 8738 Colesville Road, Silver Spring, MD 20910)
17. Janssen, R. S., Holtgrave, D. R., Valdiserri, R. O., Shepherd, M., Gayle, H. D., & De Cock, K. M. (2001). The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals. American Journal of Public Health, 91, 1019-1024.
18. Kalichman, S. C. (1996). Continued sexual risk behavior among HIV seropositive, drug-using men. Morbidity and Mortality Weekly Reports, 45, 151-152.
19. Kalichman, S. C., Rompa, D., DiFonzo, K., Simpson, D., Austin, J., Luke, W., et al. (2001). HIV treatment adherence in women living with HIV/AIDS: Research based on the information-motivation-behavioral skills model of health behavior. Journal of the Association of Nurses in AIDS Care, 12, 58-67.
20. Kalichman, S. C., Stein, J. A., Malow, R., Averhart, C., Dévieux, J., Jennings, T., et al. (in press). Predicting protected sexual behavior using the information-motivation-behavior skills (IMB) model among adolescent substance abusers in court-ordered treatment. Psychology Health and Medicine.
21. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., & Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk-factor analysis. Lancet, 357, 1397-1401.
22. Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndrome, 27, 251-259.
23. Malow, R., Peipman, F., Dévieux, F., & Lucenko, B. (2001, August). An effective HIV risk reduction intervention among severely mentally ill (SMI) alcohol and other drug (AOD) abusers. Paper presented at the National HIV Prevention Conference, Atlanta, GA.
24. Margolin, A., Avants, S. K., Warburton, L. A., & Hawkins, K. A. (2002). Factors affecting cognitive functioning in a sample of HIV-seropositive injection drug users. AIDS Patient Care & STDs, 16, 255-267.
25. McLellan, A. T., Luborksy, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease, 168, 26-33.
26. Metzger, D., Woody, G. E., Navaline, H., McLellan, A. T., Meyers, K., Boney, T., et al. (1993, October-November). The Risk Assessment Battery (RAB): Validity and reliability. Paper presented at the Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS, Alexandria, VA.
27. Miller, L. (1993). Psychotherapy of the brain injured patient. New York: Norton.
28. National Institute on Drug Abuse. (1994). Outreach/risk reduction strategies for changing HIV-related risk behaviors among injection drug users: The National AIDS Demonstration Research (NADR) Project (NIH Publication No. 94-3726). Washington, DC: U.S. Government Printing Office.
29. O'Leary, A., & National Institute of Mental Health Multisite HIV Prevention Trial Group. (2001). Social-cognitive theory mediators of behavior change in the National Institute of Mental Health multisite HIV prevention trial. Health Psychology, 20, 369-376.
30. Peipman, F. E. W., Dévieux, J. G., Malow, R. M., Lucenko, B. A., Feaster, D. J., & Kalichman, S. C. (2001, August). An evaluation of the information, motivation, and behavior (IMB) model among severely mentally ill substance abusers. Paper presented at the National HIV Prevention Conference, Atlanta, GA.
31. Sorensen, J. L., & Copeland, A. L. (2000). Drug abuse treatment as an HIV prevention strategy: A review. Drug & Alcohol Dependence, 59, 17-31.
32. Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., & Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users. Archives of Internal Medicine, 161, 1281-1288.
33. Teichner, G., Homer, M. D., & Harvey, R. T. (2001). Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. International Journal of Neuroscience, 106, 253-263.